CDC anthrax scare raises worries in U.S. Congress about lab safety

WASHINGTON (Reuters) - A growing anthrax scare at three government laboratories is drawing scrutiny from Congress about whether the U.S. Centers for Disease Control and Prevention (CDC) has the appropriate safety procedures in place to protect federal employees from contamination.

Oversight committees in both the Senate and the House of Representatives are weighing whether the potential exposure of 84 people to one of the deadliest strains of anthrax at CDC facilities in Atlanta could merit formal congressional hearings, aides said.